Skip to main content
    K

    Kiora Pharmaceuticals Inc (KPRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.93
    -0.05 (-5.30%)

    Market Cap: $5.44M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Kiora Pharmaceuticals Inc (KPRX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Kiora Pharmaceuticals (KPRX) has a market cap of $5.44M. It kept -1276.30% of revenue as net income over the last 12 months. Its share count is up 46.74% from a year earlier.

    Total Valuation

    Market Cap$5.44M
    Latest price (Nov 17, 2026)$0.93

    Key Dates

    The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 23, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.90% in the quarter ended Sep 30, 2026 and grew 22.21% a year over 2 years.

    Shares Outstanding6.30M
    Shares Change (YoY)+46.74%
    Shares Change (QoQ)+1.90%
    Share Count Growth (2Y CAGR)+22.21%

    Valuation Ratios

    Sales and book value multiples are 5.9x and 0.4x. Its year-end P/S ranged from 13.7x to 127.6x from 2016 to 2024.

    P/S Ratio5.9x
    P/B Ratio0.4x
    P/TBV Ratio0.4x

    Valuation history and multiples

    Price Statistics

    The stock is down 56.94% over 52 weeks and trades 57.92% below its 50-day average.

    Beta (1Y)1.39
    52-Week Change-56.94%
    1-Month Change-60.92%
    3-Month Change-64.23%
    6-Month Change-63.10%
    5-Year Change-99.77%
    10-Year Change-99.98%
    Total Return (1Y)-56.94%
    Total Return (3Y CAGR)-43.56%
    Total Return (5Y CAGR)-71.59%
    Max Drawdown (1Y)-67.48%
    Max Drawdown (3Y)-87.84%
    Sharpe Ratio (1Y)-1.18
    Correlation with SPY (1Y)0.28
    50-Day Average$2.21
    200-Day Average$2.36
    52-Week Range$0.95 to $2.91
    RSI (14 Days)16.3
    Average Volume (20 Days)74.24K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 7.91x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio7.91x
    Quick Ratio7.91x
    Debt / Equity0.00x
    Interest Coverage206.49x

    Returns and Efficiency

    Return on equity is -83.44% over the last 12 months, against a 5-year average of -94.32%.

    Return on Equity (ROE)-83.44%
    Return on Assets (ROA)-57.04%
    ROE (5Y Average)-94.32%
    ROA (5Y Average)-53.44%
    ROIC (5Y Average)-72.03%
    Asset Turnover0.04x
    Receivables Turnover1.16x

    Scores

    KPRX has an Altman Z-Score of -10.61, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-10.61
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $1.00M over the last 12 months.

    Revenue$1.00M
    Gross Profit$989.49K
    Operating Income-$13.72M
    Pretax Income-$13.25M
    Net Income-$12.76M
    Reported EPS (TTM)-$2.93

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 68.40% of the $22.37M in total assets.

    Cash and Equivalents$5.57M
    Total Debt$0
    Net Cash$5.57M
    Net Cash Per Share$0.88
    Working Capital$17.40M
    Shareholder Equity$15.30M
    Book Value Per Share$2.43
    Tangible Book Value$13.23M
    Tangible Book Per Share$2.10
    Total Assets$22.37M
    Total Liabilities$7.08M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $106.99K of capital spending, operating cash flow left -$7.90M of free cash flow.

    Operating Cash Flow-$7.79M
    Capital Expenditures$106.99K
    Free Cash Flow-$7.90M
    FCF Per Share-$1.79
    Depreciation and Amortization$47.46K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -1372.46%.

    Gross Margin98.95%
    Operating Margin-1372.46%
    Pretax Margin-1324.80%
    Net Margin-1276.30%
    FCF Margin-789.82%

    Dividends and Yields

    KPRX does not pay a dividend. Its free cash flow yield is -134.91%.

    FCF Yield-134.91%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-9 reverse split on Jun 11, 2024.

    Last Split DateJun 11, 2024
    Split TypeReverse split
    Split Ratio1:9

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About KPRX

    What is KPRX's market cap?

    Kiora Pharmaceuticals has a market cap of $5.44M.

    How many shares of KPRX are outstanding?

    Kiora Pharmaceuticals has 6.30M shares outstanding. The count is up 46.74% from a year earlier.

    Does KPRX pay a dividend?

    No. Kiora Pharmaceuticals does not pay a dividend.

    How much debt does KPRX have?

    Kiora Pharmaceuticals has $0 of total debt and $5.57M of cash and equivalents, a net cash position of $5.57M.